The High-Affinity Chymotrypsin Inhibitor Eglin C Poorly Inhibits Human Chymotrypsin-Like Protease: Gln192 and Lys218 Are Key Determinants
Structural biology article published in Proteins (2024)
Abstract
Eglin C, a small protein from the medicinal leech, has been long considered a general high-affinity inhibitor of chymotrypsins and elastases. Here, we demonstrate that eglin C inhibits human chymotrypsin-like protease (CTRL) weaker by several orders of magnitude than other chymotrypsins. In order to identify the underlying structural aspects of this unique deviation, we performed comparative molecular dynamics simulations on experimental and AlphaFold model structures of bovine CTRA and human CTRL. Our results indicate that in CTRL, the primary determinants of the observed weak inhibition are amino-acid positions 192 and 218 (using conventional chymotrypsin numbering), which participate in shaping the S1 substrate-binding pocket and thereby affect the stability of the protease-inhibitor complexes.
Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.
Summary
Comparative molecular dynamics simulations of bovine and human chymotrypsin-like structures show that eglin C, a leech protein long considered a general chymotrypsin inhibitor, inhibits human chymotrypsin-like protease far more weakly, with residues Gln192 and Lys218 identified as key determinants of this weak inhibition.
Why This Matters for Hirudotherapy
This study examined why eglin C—a small protein from the medicinal leech long regarded as a general high-affinity inhibitor of chymotrypsins and elastases—weakly inhibits human chymotrypsin-like protease (CTRL) by several orders of magnitude compared with other chymotrypsins. Using comparative molecular dynamics simulations on bovine CTRA and human CTRL structures, the authors identified amino-acid positions 192 and 218 as key determinants shaping the S1 substrate-binding pocket and affecting protease-inhibitor complex stability. Eglin C is a characterized leech-secretome inhibitor. The study is computational/in silico (molecular dynamics), provides structural-mechanistic insight only, and offers no therapeutic or in-vivo data.
Citation
Reference (Vancouver style)
Németh BZ, Kiss B, Sahin-Tóth M, Magyar C, Pál G. The High-Affinity Chymotrypsin Inhibitor Eglin C Poorly Inhibits Human Chymotrypsin-Like Protease: Gln192 and Lys218 Are Key Determinants. Proteins. 2025;93(2):543-554. doi:10.1002/prot.26750. PMID: 39301701
Bibliographic details (authors, volume, pages, DOI) are taken from the PubMed record.
Added to ASH library: May 26, 2026 · Site last updated: June 18, 2026